Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2013-08-14
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 5
- Registration Number
- NCT00304018
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 9
- Registration Number
- NCT00303992
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2012-10-02
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT00301912
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2013-07-15
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 8
- Registration Number
- NCT00301860
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 7
- Registration Number
- NCT00301951
- Locations
- 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
- Conditions
- Interventions
- Biological: alemtuzumabDrug: busulfanDrug: cyclosporineDrug: fludarabine phosphateDrug: methotrexateDrug: methylprednisoloneProcedure: allogeneic bone marrow transplantationProcedure: allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantationProcedure: umbilical cord blood transplantation
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2017-09-28
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 35
- Registration Number
- NCT00301834
- Locations
- 🇺🇸
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, United States
🇺🇸UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Radiation Therapy in Treating Women With Invasive Breast Cancer
- Conditions
- First Posted Date
- 2006-03-10
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 20
- Registration Number
- NCT00301041
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Smoking Treatment in HIV Clinical Care Settings
- Conditions
- Interventions
- First Posted Date
- 2006-02-28
- Last Posted Date
- 2012-06-27
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 207
- Registration Number
- NCT00297453
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
- Conditions
- Interventions
- Biological: anti-thymocyte globulinBiological: therapeutic allogeneic lymphocytesDrug: fludarabine phosphateDrug: thiotepaProcedure: allogeneic bone marrow transplantationProcedure: allogeneic hematopoietic stem cell transplantationProcedure: in vitro-treated peripheral blood stem cell transplantationRadiation: total-body irradiation
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2012-11-12
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 21
- Registration Number
- NCT00295971
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
- Conditions
- Interventions
- Biological: anti-thymocyte globulinBiological: filgrastimBiological: therapeutic allogeneic lymphocytesDrug: busulfanDrug: fludarabine phosphateDrug: methotrexateDrug: tacrolimusProcedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2012-10-04
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 25
- Registration Number
- NCT00296023
- Locations
- 🇺🇸
Alta Bates Comprehensive Cancer Center, Berkeley, California, United States
🇺🇸UCSF Comprehensive Cancer Center, San Francisco, California, United States